Loading clinical trials...

Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease | Clinical Trials | Clareo Health

COMPLETED

Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease

A Postmarketing Observational Study Estimating The Impact Of Prevnar 13 (Trade Mark) (13vpnc) On Invasive Pneumococcal Disease Caused By Vaccine Serotypes Of Streptococcus Pneumoniae After Introduction Into Routine Pediatric Use

NCT01128439•Pfizer

View on ClinicalTrials.gov

Summary

This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.

Detailed Description

No sampling as no subjects are enrolled

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Documented invasive pneumococcal disease (IPD), defined as recovery of an isolate of S pneumoniae from a normally sterile site in a member of the surveillance population.

Exclusion Criteria

•None

Locations (1)

Kaiser Permanente Vaccine Study Center

Oakland, California, United States

Key Dates

Start Date

July 1, 2010

Primary Completion Date

April 1, 2015

Completion Date

April 1, 2015

Last Updated

December 4, 2018

Enrollment

ACTUAL participants

Conditions

Invasive Pneumococcal Disease

Interventions

No intervention

OTHER

An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years

NCT04464291

Pneumonia, PneumococcalInvasive Pneumococcal Disease+1 more

View study

COMPLETED

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

NCT00227188

Invasive Pneumococcal Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions